Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers

Persistent Link:
http://hdl.handle.net/10150/610131
Title:
Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers
Author:
Fadare, Oluwole; Zheng, Wenxin
Affiliation:
Department of Pathology, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas, USA; Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA; Department of Pathology, Department of Obstetrics and Gynecology, and the Arizona Cancer Center, University of Arizona College of Medicine, Tucson, Arizona, USA; Department of Pathology and Hospital of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China
Issue Date:
2008
Publisher:
BioMed Central
Citation:
Diagnostic Pathology 2008, 3:6 doi:10.1186/1746-1596-3-6
Journal:
Diagnostic Pathology
Rights:
© 2008 Fadare and Zheng; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0)
Collection Information:
This item is part of the UA Faculty Publications collection. For more information this item or other items in the UA Campus Repository, contact the University of Arizona Libraries at repository@u.library.arizona.edu.
Abstract:
In this article, the authors briefly review the historical evolution of the various putative precursor lesions for Type II endometrial cancers, with an emphasis on the newly defined "Endometrial Glandular Dysplasia (EmGD)". The evidentiary basis for delineating serous EmGD as the most probable precursor lesions to endometrial serous carcinoma is reviewed in detail. An argument is advanced for the discontinuation of the term serous "endometrial intraepithelial carcinoma (EIC)" as a descriptor for a supposedly intraepithelial, precancerous lesion. Preliminary evidence is also presented that suggests that there is a morphologically recognizable "clear cell EmGD" that probably represents a precancerous lesion to endometrial clear cell carcinomas.
EISSN:
1746-1596
DOI:
10.1186/1746-1596-3-6
Version:
Final published version
Additional Links:
http://www.diagnosticpathology.org/content/3/1/6

Full metadata record

DC FieldValue Language
dc.contributor.authorFadare, Oluwoleen
dc.contributor.authorZheng, Wenxinen
dc.date.accessioned2016-05-20T08:59:15Z-
dc.date.available2016-05-20T08:59:15Z-
dc.date.issued2008en
dc.identifier.citationDiagnostic Pathology 2008, 3:6 doi:10.1186/1746-1596-3-6en
dc.identifier.doi10.1186/1746-1596-3-6en
dc.identifier.urihttp://hdl.handle.net/10150/610131-
dc.description.abstractIn this article, the authors briefly review the historical evolution of the various putative precursor lesions for Type II endometrial cancers, with an emphasis on the newly defined "Endometrial Glandular Dysplasia (EmGD)". The evidentiary basis for delineating serous EmGD as the most probable precursor lesions to endometrial serous carcinoma is reviewed in detail. An argument is advanced for the discontinuation of the term serous "endometrial intraepithelial carcinoma (EIC)" as a descriptor for a supposedly intraepithelial, precancerous lesion. Preliminary evidence is also presented that suggests that there is a morphologically recognizable "clear cell EmGD" that probably represents a precancerous lesion to endometrial clear cell carcinomas.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urlhttp://www.diagnosticpathology.org/content/3/1/6en
dc.rights© 2008 Fadare and Zheng; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0)en
dc.titleEndometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancersen
dc.typeArticleen
dc.identifier.eissn1746-1596en
dc.contributor.departmentDepartment of Pathology, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas, USAen
dc.contributor.departmentDepartment of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USAen
dc.contributor.departmentDepartment of Pathology, Department of Obstetrics and Gynecology, and the Arizona Cancer Center, University of Arizona College of Medicine, Tucson, Arizona, USAen
dc.contributor.departmentDepartment of Pathology and Hospital of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, Chinaen
dc.identifier.journalDiagnostic Pathologyen
dc.description.collectioninformationThis item is part of the UA Faculty Publications collection. For more information this item or other items in the UA Campus Repository, contact the University of Arizona Libraries at repository@u.library.arizona.edu.en
dc.eprint.versionFinal published versionen
All Items in UA Campus Repository are protected by copyright, with all rights reserved, unless otherwise indicated.